EUROFINS SCIENTIFIC (ERF.PA) Stock Fundamental Analysis
Europe - EPA:ERF - FR0014000MR3 - Common Stock
57.55 EUR
-1.17 (-1.99%)
Overall ERF gets a fundamental rating of 6 out of 10. We evaluated ERF against 18 industry peers in the Life Sciences Tools & Services industry. ERF has an average financial health and profitability rating. ERF scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, ERF could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year ERF was profitable.
In the past year ERF had a positive cash flow from operations.
In the past 5 years ERF has always been profitable.
In the past 5 years ERF always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of ERF (3.54%) is comparable to the rest of the industry.
ERF has a Return On Equity (8.09%) which is in line with its industry peers.
ERF has a better Return On Invested Capital (9.79%) than 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ERF is significantly below the industry average of 13.84%.
The last Return On Invested Capital (9.79%) for ERF is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROIC | 9.79% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
With a Profit Margin value of 5.44%, ERF is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of ERF has grown nicely.
Looking at the Operating Margin, with a value of 15.59%, ERF is in line with its industry, outperforming 55.56% of the companies in the same industry.
ERF's Operating Margin has improved in the last couple of years.
The Gross Margin of ERF (23.29%) is worse than 83.33% of its industry peers.
ERF's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ERF is still creating some value.
The number of shares outstanding for ERF has been reduced compared to 1 year ago.
The number of shares outstanding for ERF has been increased compared to 5 years ago.
Compared to 1 year ago, ERF has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.64 indicates that ERF is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.64, ERF perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of ERF is 5.25, which is a neutral value as it means it would take ERF, 5.25 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.25, ERF is doing good in the industry, outperforming 66.67% of the companies in the same industry.
ERF has a Debt/Equity ratio of 0.77. This is a neutral value indicating ERF is somewhat dependend on debt financing.
ERF has a worse Debt to Equity ratio (0.77) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Altman-Z | 2.64 |
ROIC/WACC1.23
WACC7.94%
2.3 Liquidity
ERF has a Current Ratio of 1.26. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
ERF has a Current ratio (1.26) which is in line with its industry peers.
A Quick Ratio of 1.19 indicates that ERF should not have too much problems paying its short term obligations.
ERF's Quick ratio of 1.19 is amongst the best of the industry. ERF outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
ERF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.50%, which is quite good.
Measured over the past years, ERF shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
The Revenue has been growing slightly by 2.53% in the past year.
The Revenue has been growing by 8.78% on average over the past years. This is quite good.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
3.2 Future
Based on estimates for the next years, ERF will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.60% on average per year.
Based on estimates for the next years, ERF will show a small growth in Revenue. The Revenue will grow by 7.37% on average per year.
EPS Next Y14.65%
EPS Next 2Y13.56%
EPS Next 3Y14%
EPS Next 5Y15.6%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.91%
Revenue Next 5Y7.37%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ERF is valuated correctly with a Price/Earnings ratio of 15.99.
Based on the Price/Earnings ratio, ERF is valued cheaper than 88.89% of the companies in the same industry.
ERF's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.56.
A Price/Forward Earnings ratio of 14.45 indicates a correct valuation of ERF.
ERF's Price/Forward Earnings ratio is rather cheap when compared to the industry. ERF is cheaper than 88.89% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.62, ERF is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.99 | ||
| Fwd PE | 14.45 |
4.2 Price Multiples
83.33% of the companies in the same industry are more expensive than ERF, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ERF indicates a rather cheap valuation: ERF is cheaper than 94.44% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.37 | ||
| EV/EBITDA | 8.27 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ERF may justify a higher PE ratio.
ERF's earnings are expected to grow with 14.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.09
PEG (5Y)0.87
EPS Next 2Y13.56%
EPS Next 3Y14%
5. Dividend
5.1 Amount
ERF has a Yearly Dividend Yield of 1.01%.
Compared to an average industry Dividend Yield of 0.74, ERF pays a better dividend. On top of this ERF pays more dividend than 88.89% of the companies listed in the same industry.
With a Dividend Yield of 1.01, ERF pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.01% |
5.2 History
The dividend of ERF is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ERF pays out 54.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ERF is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y13.56%
EPS Next 3Y14%
EPA:ERF (11/18/2025, 5:29:59 PM)
57.55
-1.17 (-1.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners37.21%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap10.48B
Revenue(TTM)6.89B
Net Income(TTM)374.80M
Analysts69.47
Price Target64.78 (12.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.01% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.48%
PT rev (3m)-0.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.09%
EPS NY rev (3m)-0.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.99 | ||
| Fwd PE | 14.45 | ||
| P/S | 1.52 | ||
| P/FCF | 13.37 | ||
| P/OCF | 7.97 | ||
| P/B | 2.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.27 |
EPS(TTM)3.6
EY6.26%
EPS(NY)3.98
Fwd EY6.92%
FCF(TTM)4.3
FCFY7.48%
OCF(TTM)7.22
OCFY12.54%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.09
PEG (5Y)0.87
Graham Number45.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROCE | 12.64% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.74% | ||
| ROICexgc | 34.1% | ||
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Debt/EBITDA | 2.1 | ||
| Cap/Depr | 84.94% | ||
| Cap/Sales | 7.7% | ||
| Interest Coverage | 9.93 | ||
| Cash Conversion | 77.37% | ||
| Profit Quality | 209.21% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.64 |
F-Score7
WACC7.94%
ROIC/WACC1.23
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.65%
EPS Next 2Y13.56%
EPS Next 3Y14%
EPS Next 5Y15.6%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.91%
Revenue Next 5Y7.37%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year86.11%
EBIT Next 3Y30.34%
EBIT Next 5Y22.42%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%
EUROFINS SCIENTIFIC / ERF.PA FAQ
What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ERF.PA.
Can you provide the valuation status for EUROFINS SCIENTIFIC?
ChartMill assigns a valuation rating of 7 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Undervalued.
Can you provide the profitability details for EUROFINS SCIENTIFIC?
EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 6 / 10.
How financially healthy is EUROFINS SCIENTIFIC?
The financial health rating of EUROFINS SCIENTIFIC (ERF.PA) is 5 / 10.
Is the dividend of EUROFINS SCIENTIFIC sustainable?
The dividend rating of EUROFINS SCIENTIFIC (ERF.PA) is 4 / 10 and the dividend payout ratio is 54.91%.